InsiderTrades

Form 4 for HIMS Hims & Hers Health, Inc.

Accepted 2026-02-04 00:00:00 ET · period of report 2026-02-03 · accession 0001907056-26-000006 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2026-02-04 2026-02-03 HIMS Okupe Oluyemi CFO M - OptEx $5.01 +5,262 96.9K +6% +$26.4K
D 2026-02-04 2026-02-03 HIMS Okupe Oluyemi CFO S - Sale+OE $26.44 -5,262 91.6K -5% -$139.1K
D 2026-02-04 2026-02-03 HIMS Okupe Oluyemi CFO M - OptEx $0.00 -5,262 144.1K -4% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2026-02-03 M A 5,262 $5.01 96,879 D — —
2 Common Class A Common Stock 2026-02-03 S D 5,262 $26.44 91,617 D — — (F2) Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $26.35-$26.56. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
3 Derivative Stock Option (right to buy) 2026-02-03 M D 5,262 $0.00 144,051 D $5.01 · — to 2032-02-23 5,262 Class A Common Stock (F3) The Reporting Person received stock options to purchase shares of Class A Common Stock. The stock options vest over a 4-year period, with 1/48 of the shares vesting when the Reporting Person completes each month of continuous service, beginning March 24, 2022.